Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies
100.0
%
| 2 | 100.0 % | 6 | 100.0 % | +202.12% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 6 | 100.0 % | +202.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Wolf
CEO | Chief Executive Officer | 60 | 08-06-09 |
Director of Finance/CFO | 56 | 19-09-24 | |
Guillermo Arana
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
David Waldman
IRC | Investor Relations Contact | - | - |
Paul Tebbey
PRN | Corporate Officer/Principal | - | 21-10-05 |
George Peoples
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Prendergast
BRD | Director/Board Member | 70 | 16-04-25 |
Jeff Wolf
CEO | Chief Executive Officer | 60 | 08-06-09 |
Edward Smith
BRD | Director/Board Member | 48 | 08-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 09-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,031,964 | 34,120,048 ( 94.69 %) | 0 | 94.69 % |
Company contact information
Scorpius Holdings, Inc.
627 Davis Drive Suite 300
27560, Morrisville
+919 240 7133
http://www.nighthawkbio.comSector
1st Jan change | Capi. | |
---|---|---|
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |